Cryopreservation Bags and Freezing Bags Market to Reach USD 1.12 Billion by 203

Sub-Headline: The global Cryopreservation Bags and Freezing Bags Market is set to grow from USD 620 million in 2023 to USD 1.12 billion by 2030, registering a robust CAGR of 8.7%, driven by rising demand for cell banking, biobanking, stem cell storage, and advanced regenerative medicine applications.

Introduction
The Cryopreservation Bags and Freezing Bags Market is witnessing strong growth as biotechnology companies, stem cell banks, biopharmaceutical manufacturers, and research laboratories increasingly depend on advanced cryogenic storage solutions for long-term preservation of cells, tissues, vaccines, mRNA samples, cord blood, and CAR-T therapy materials.

Cryopreservation bags play a critical role in maintaining viability, sterility, and structural integrity during freezing, storage, and transportation under ultra-low temperature conditions-typically using liquid nitrogen (LN2), vapor-phase freezers, or ultra-deep freezers.
As cell & gene therapy approvals rise and global biobanking infrastructure expands, demand for standardized, sterile, leak-proof freezing bags continues to accelerate.

Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/73513

Key Takeaways
• Market Size (2023): USD 620 Million
• Expected Market Size (2030): USD 1.12 Billion
• CAGR (2024-2030): 8.7%
• High adoption driven by cell & gene therapy manufacturing and stem cell banking.
• Major players include Cytiva (GE Healthcare), Sartorius, Thermo Fisher Scientific, OriGen Biomedical, Charter Medical, Cryo Bio System, Miltenyi Biotec, WuXi Advanced Therapies, Merck KGaA, and BioLife Solutions.
• Increasing demand for sterile, validated, and regulatory-compliant cryopreservation consumables.

Market Story
Cryopreservation is a foundational requirement for regenerative medicine, biopharma manufacturing, and advanced cellular therapy development. Freezing bags ensure:
• High cell viability
• Sterility under cryogenic conditions
• Minimal risk of contamination or leakage
• Compliance with GMP, ISO, and regulatory storage guidelines
Growing adoption of personalized medicine, CAR-T therapy, RNA-based vaccines, donor cell banking, and umbilical cord stem cell storage is driving rapid market expansion.

Three Key Growth Drivers
1. Expansion of Cell & Gene Therapy Pipelines
Over 2,000 active gene therapy clinical trials globally require scalable, reliable cryopreservation solutions.

2. Biobanking Boom
Governments and private institutions are investing heavily in:
• Population biobanks
• Cord blood banks
• Tumor biorepositories
• Fertility & reproductive biobanking

3. Technological Advancements
New bag designs improve:
• Cryo-resistance
• Flexibility
• Material biocompatibility
• RFID-enabled traceability
• Closed-system filling and sealing

Explore Full Report here:
https://exactitudeconsultancy.com/reports/73513/cryopreservation-bags-and-freezing-bags-market

Market Segments
By Product Type
• Cryopreservation Bags (largest share)
• Freezing Bags
• Cryogenic Vials/Bottles (within multi-packaging systems)
By Material
• EVA (Ethylene Vinyl Acetate) - most widely used
• PE (Polyethylene)
• PET & Laminated Multilayer Films
• Other Cryo-Compatible Polymers

By Application
• Cord Blood & Stem Cell Banking
• Cell & Gene Therapy Manufacturing
• Biobanking & Biorepositories
• Clinical Sample Storage
• Cryogenic Transport Logistics

By End User
• Biotechnology & Pharmaceutical Companies
• Stem Cell Banks
• Academic & Research Institutes
• Contract Development & Manufacturing Organizations (CDMOs)
• Hospitals & Transplant Centers

Recent Developments
• Cytiva expanded its cryobag portfolio with improved LN2-resistant multilayer films.
• Sartorius introduced sterile, single-use cryopreservation systems integrated with closed aseptic filling.
• Thermo Fisher launched traceability-enabled freezing bags compatible with automated cryogenic storage.
• OriGen Biomedical rolled out EVA-based cryo bags optimized for CAR-T and NK-cell therapy.
• Miltenyi Biotec unveiled enhanced cryopreservation solutions for GMP-grade cell therapy materials.
• BioLife Solutions strengthened its cold-chain logistics and cryogenic storage capabilities.

Get Your Exclusive Offer with up to 10% Discount
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=73513

Expert Quote
"Cryopreservation is the backbone of next-generation cell and gene therapies. As global demand for advanced biological treatments grows, high-quality cryogenic storage bags are becoming mission-critical for ensuring viability, sterility, and regulatory compliance."
-Irfan Tamboli, Business Development Executive, Exactitude Consultancy

Market Drivers
• Rapid growth in stem cell & cell therapy research
• Rising approvals of CAR-T and gene therapy products
• Increasing investments in biobanking & biorepositories
• Higher demand for safe cryogenic transport systems
• Technological improvements in cryo-tolerant polymer materials
• Growing adoption of GMP-compliant and single-use sterile packaging

Forecast Outlook
The market is expected to reach USD 1.12 billion by 2030, supported by:
• Growth in advanced therapeutics manufacturing
• Global expansion of stem cell banking networks
• Increased adoption of cryogenic logistics in biopharma
• Rising clinical trials in regenerative medicine
Regional Highlights
• North America leads due to strong cell therapy pipelines and biobanking infrastructure.
• Europe follows with stringent regulatory standards and government-funded cell therapy programs.
• Asia-Pacific is the fastest-growing region, driven by stem cell banking in China, India, Japan, and South Korea.

Government & Regulatory Initiatives
• FDA and EMA guidelines for cell therapy cryopreservation
• NIH-funded cryogenic storage and biobanking programs
• EU biobanking & research infrastructure initiatives (BBMRI-ERIC)
• National stem cell repository programs across Asia-Pacific
• Regulatory mandates for GMP-compliant cryogenic storage

Conclusion
The Cryopreservation Bags and Freezing Bags Market is positioned for significant growth as cell therapy, biobanking, and advanced regenerative medicine continue to expand globally. Manufacturers focusing on sterile, high-performance, and GMP-compliant cryogenic solutions will capture the strongest opportunities through 2030.

This report is also available in the following languages : Japanese (凍結保存バッグおよび冷凍バッグ市場), Korean (냉동보관백 및 냉동백 시장), Chinese (冷冻保存袋和冷冻袋市场), French (Marché des sacs de cryoconservation et des sacs de congélation), German (Markt für Kryokonservierungsbeutel und Gefrierbeutel), and Italian (Mercato delle sacche per crioconservazione e delle sacche per congelamento), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/73513

Our More Reports:

Anime Movies and TV Show Market
https://exactitudeconsultancy.com/reports/74633/anime-movies-and-tv-show-market

Digital Rights Management Market
https://exactitudeconsultancy.com/reports/74634/digital-rights-management-market

Smart Advertising Market
https://exactitudeconsultancy.com/reports/74635/smart-advertising-market

AdTech Market
https://exactitudeconsultancy.com/reports/74636/adtech-market

https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.

This release was published on openPR.